Jin Medical International Ltd.(ZJYL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-09-30.

Jin Medical International Ltd. (ZJYL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ZJYL is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $23.5m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Jin Medical International Ltd. reports quarterly revenue of $20.7M, net income of $1.2M, an operating margin of 2.9%. Top institutional holders of ZJYL by reported 13-F value include CITADEL ADVISORS, GEODE CAPITAL MANAGEMENT, JANE STREET GROUP, based on the most recent SEC filings. ZJYL trades on the Nasdaq exchange and files with the SEC under CIK 1837821. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZJYL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Jin Medical International Ltd. directly from SEC EDGAR.